Innovate UK Biomedical Catalyst

Fund Name: Biomedical Catalyst
Project Length: 6 - 36 Months
Project Value: Up to £8M
Deadline: 06/06/2018

Biomedical Catalyst

The aim of the Biomedical Catalyst fund is to support the development of innovative healthcare products, technologies and processes. These can include:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The Biomedical Catalyst has 4 types of funding award. These are: feasibility, primer, early stage and late stage. They are designed to help SMEs developing a product or process to provide an innovative solution to a health and care challenge. The scheme supports progression from initial concept through to late stage development.

Primer award in the Biomedical Catalyst – Up to £4M

The aim of this award is to conduct a technical evaluation of your idea through to proof of concept in a model system, and can include:

  • experimental evaluation (at laboratory scale)
  • initial demonstration using in vitro and in vivo models (but not human clinical trials such as safety or efficacy)
  • exploring potential production mechanisms
  • early-stage prototyping
  • product development planning
  • intellectual property protection

Projects can be from any sector or discipline, including (but not limited to):

  • stratified healthcare (both therapeutic and diagnostic components)
  • advanced therapies (gene and cell therapies)
  • diagnostics
  • digital health
  • medical technologies and devices

Late stage award in the Biomedical Catalyst – Up to £8M

The aim of this award is to support projects which test a well-developed concept and show its effectiveness in an environment that is relevant to the use of the product or process. A late stage project can include:

  • initial human proof-of-concept studies
  • demonstration of clinical utility and effectiveness
  • demonstration of safety and efficacy (including phase I and II clinical trials)
  • developing production mechanisms
  • prototyping
  • market testing
  • intellectual property protection

These solutions should be innovative healthcare technologies, products or processes that will help provide at least one of the following:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • treatments that either change underlying disease or offer potential cures

Projects will be supported from any sector or discipline, including (but not limited to):

  • advanced therapies (cell and gene therapy)
  • precision medicine (both therapy and diagnostic components)
  • diagnostics
  • digital health
  • medical technologies and devices

If you think that you might be eligible for any of these funds, please contact us – we’re happy to discuss your eligibility over the phone or email. Please call 01392 427860 or email info@grantedltd.co.uk

Back to all funds